Download Invited Presentations - University of Manitoba

INVITED PRESENTATIONS JULY 1, 2006 – JUNE 30, 2007
Michelle Alfa
“Nosocomial Models: Clostridium difficile.” Presented at World Healthcare Associated Infection (HAI) Forum –
2007. Veyrier-du-Lac, France. June 4, 2007.
“Clostridium difficile Update.” Presented at the Webber Training and Teleconference. December 14, 2006.
“Water Quality; Issues Related to Medical Device Reprocessing.” Presented at 2006 Infection Control Forum.
Cleveland, Ohio. October 9, 2006.
“Slip-sliding Away! Clostridium difficile.” Presented at Chatham-Kent Infection Control Committee (C-KICC in
Action. 9th Annual Infection Control Conference.) Chatham, Ontario. October 18, 2006.
“Handwashing, Gloving and Waterless Handwash; The Good, The Bad and the Ugly.” Presented at Chatham-Kent
Infection Control Committee (C-KICC in Action. 9th Annual Infection Control Conference.) Chatham, Ontario.
October 18, 2006.
“Addressing the Challenges of Cleaning Devices.” Presented at Re-Processing Medical Devices – Addressing the
Issues of Single-Use Devices in a Changing Medical Environment. The Old Mill, Toronto. September 20, 2006.
“Medical Devices.” Presented at Superbugs: Today and Tomorrow – 2006 C.S.A.O. Conference. Chatham,
Ontario. September 19, 2006.
“The New Scoop on some Old Poop. Best Practices in Controlling Infection from Clostridium Difficile.” Presented
at CIARE Professional Development Symposium. Winnipeg, MB. May 10, 2007.
Anton Andonov
SARS-Coronavirus Interaction with ACE2 Receptor; Implications for Virus Adaptation and Vaccine Design. XIth
Congress of the Bulgarian Microbiologists, October, 5-7, 2006, Varna, Bulgaria.
Fred Aoki
Can We Prevent Cervical Cancer? CancerCare Manitoba Eradicating Cervical Cancer Course, Winnipeg, MB. Nov
17, 2006.
Herpes Simplex & Human Papilloma Virus Infections…Are They Preventable? Woman and Child Program (St.
Boniface General Hospital), Winnipeg, MB. May 4, 2007.
Harvey Artsob
Travel-related arbovirus and hantavirus infections in Canadians. Committee to Advise on Travel Medicine and
Travel (CATMAT) Nov 1, Ottawa, Ontario, 2006.
Emerging and neglected infectious diseases and zoonoses from a Canadian perspective. CIHR Canada-Germany
Collaboration on Infectious Disease. Nov 6-7, Montreal, Quebec, 2006.
Update on dengue plaque reduction neutralization test validation panels. Meeting of the WHO Task Force on
Clinical Trials of Dengue Vaccines Nov 11, Atlanta, Georgia, 2006.
Arboviruses and human disease risk in Canada. Ontario Vector Control Association Feb 15, Mississauga, Ontario,
2007.
Canadian Public Health Laboratory Network (CPHLN) lab testing guidelines for Lyme disease in Canada. National
Non-Enteric Zoonotic Diseases Meeting March 21-22, Montreal, Quebec, 2007.
Influence of biodiversity and environmental factors on zoonoses. First International symposium on “The Role of
the Environment in the Interface between Microorganisms and Humans”. April 13, Saint Etienne, France, 2007.
Reagents for dengue neutralization test assay harmonization. Meeting of the WHO Steering Committee on
Dengue and other Flavivirus Vaccines. April 24-25, Ho Chi Minh City, Vietnam, 2007.
Emerging and re-emerging diseases-the cycle continues. First Canadian Symposium on the Hygiene Profession
and Science: an Integrated view. June 21, Hamilton, Ontario, 2007.
Stephanie Booth
Invited seminar at the University of Alberta, Edmonton, “Transcriptional profiling of prion diseases; from mRNA to
miRNA”, (2007).
2nd Government Related TSE Research Meeting “Identification of non-prion biomarkers for TSE detection”,
(2006).
Timothy Booth
Meeting: NIC Meeting (Senior Canadian Host on behalf of Dr. Plummer). Toronto, ON June 14 - 15, 2007. 2007.
Speaker: Welcome and Opening Remarks.
Speaker: Detection of airborne infectious agents. Science Symposium on Airborne Infectious Diseases, Exposure
Pathways, Controls and Interventions: What is known? American Industrial Hygiene Conference and Exhibition
(AIHce 2007), Convention Center, Philadelphia, June 4th 2007.
Pandemics: Past, Present and Future. Keynote presentation. Annual Conference of the Manitoba Social Science
Teachers, Winnipeg, Manitoba. Invited lecture, November 24, 2006.
Introduction to influenza surveillance and avian influenza- current worldwide outbreaks and pandemic fears.
Influenza molecular diagnostics workshop, National Microbiology Laboratory, October 24 th 2006.
Eric Bow
International Immunocompromised Host Society (ICHS), July 2-5, 2006
Crans Montana, Switzerland
Symposium: Considerations in the Prevention and Management of Invasive Fungal Infections in the
Immunocompromised Host
Presentation: “Appropriate Use of Antifungal Therapy – Implementation into Practice”
Asia Anti-Infectives Expert Panel Meeting, Bangkok, Thailand, July 10-11, 2006
Presentation: “Management of invasive fungal infections in high risk patients: a hematological focus”
10th Congress of the Brazilian Society of Bone Marrow Transplantation, August 16-18, 2006, Curitiba, Brazil
Meet the Professor Session: “Current Approaches to the Diagnosis and Management of Viral Infections after Stem
Cell Transplantation: EBV, CMB, HHV6” (w/ Drs. Nucci & Cunha)
Scientific Session: “The role of antibacterial prophylaxis and empirical antibacterial therapy in neutropenic
patients”
Plenary Session: “Current therapy of fungal infections after HSCT: New drugs and the role of combination
therapy”
46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
(ICAAC), San Francisco, CA, September 26, 2006
Symposium: New Approaches to the Treatment of Fungal Infections
Presentation: “Preventative strategies for invasive fungal infections”
China National Hematology Annual Congress, Nanjing, China, October 20-27, 2006
Presentation: “Management strategy for invasive fungal infection in immunosuppressive patients”
China National ICU Annual Congress, Shenyang, China
Presentation: “Management strategy for invasive fungal infection and the role of voriconazole among all
antifungal medicines”
Similar lecture presentations x 3 to Chinese ID & ICU physicians, hematologists, pulmonologists in Beijing,
Shanghai, Guangzhou, and Hong Kong, China
2 Lecture presentations on “Early diagnosis and treatment of invasive fungal infections – new approaches” in
Hong Kong, China.
2006 Canadian Fungal Forum, St. Joseph’s Healthcare, Hamilton, Ontario, October 29, 2006
Presentation: “Combination Anti-fungal Chemotherapy: Can we afford not to …?”
48th Annual Meeting of the American Society of Hematology (ASH), Orlando, Florida, December 8, 2006
ASH Education Program: Supportive Care of Infections in Patients with Hematologic Malignancies
Presentation: Of Yeasts and Hyphae: Medical Mycology for the Hematologist”
33rd Annual Meeting of European Group for Blood and Marrow Transplantation, Lyon, France, March 25-28, 2007
Symposium: Countering the Threat of Fungal Infections in the Hematology Setting
Presentation: “Managing fungal infections in HSCT patients”
Presentations x 2 to Japanese hematologists in attendance at EBMT
“New strategies for the treatment of severe fungal infections on stem cell transplantation patients”
Society of Community Internists and General Internists North of the Malahat, Tofino, Vancouver Island, British
Columbia, April 21, 2007
Presentation: “Approach to the febrile neutropenic cancer patient. Sorry, no beds; you’ll have to go home”
7th Spring Conference on Clinical Pharmacy by the European Society of Clinical Pharmacy (ESCP), Edinburgh,
Scotland, May 16-28, 2007
Symposium: Clinical and Economic Burden of ICU Infections
Presentation: “The Burden of Fungal Infections”
VFEND Speaker Training Program, Vienna, Austria, June 5, 2007
Presentation: VFEND Clinical Research Update
Clifford Clark
St. Boniface Hospital Laboratory. A review of E. coli O157:H7 and non-O157:H7 STEC. February 7, 2007.
Markus Czub
Weingartl, H.M., Y. Berhane, B. Sawatsky, C. Ranadheera & M. Czub. (2007). Pathogenesis, prevention and
diagnosis of Nipah virus (oral presentation). EPIZONE Annual Meeting, Poland.
Czub M. and Weingartl H (2006) Nipah, Hendra and Crimean-Congo-Hemorrhagic-fever viruses: re-emerging,
virulent and zoonotic pathogens, Abstract/Oral presentation; June 25 - 29; International Veterinary Vaccines and
Diagnostics Conference, Oslo, Norway.
Lawrence Elliott
International Centre for Infectious Diseases Research and Innovation Retreat, Winnipeg, October 2006, “The
Shifting Epidemiology of HIV in Manitoba”.
Global College, University of Winnipeg, Summer Institute in Infectious Diseases II, June 2007, “From Global to
Local: The Epidemiology of HIV”.
John Embil
Osteomyelitis: More than a Non-Healing Wound. Canadian Dermatology Association 81st Annual Conference,
Winnipeg, Manitoba, July 1, 2006.
Out Damned Bug! City-Wide Emergency Rounds, University of Manitoba, Winnipeg, Manitoba, September 20,
2006.
Therapy of Skin and Soft Tissue Infections: Skin and Soft-Tissue Infections. Canadian Clinical Practice
Guidelines Authors, Working Group Meeting. Toronto, Ontario, October 12, 2006.
Meet the Professor: Osteomyelitis and Prosthetic Joint Infections. Infectious Diseases Society of America
Meeting, Toronto, Ontario, October 15, 2006.
Infection Control: Why We Do What We Do. Bug Day, Health Sciences Centre, Winnipeg, Manitoba, October 17,
2006.
Diabetic Foot Infections – Overview. Investigator Meeting. A Multi-Centre, Randomized, Double-Blind,
Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigacycline versus Ertapanem for the
Treatment of Foot Infections in Subjects with Diabetes. Protocol 3074K5-319-WW. San Diego, California
November 9, 2006.
Blastomycosis: Epidemiology, Clinical Manifestations and Medical Management. Canadian Association of
Neuroscience Nurses. College of Registered Nurses of Manitoba, Winnipeg, Manitoba, November 21, 2006.
Expect the Unexpected: An Interactive Discussion about Infectious Diseases Cases: Infectious Diseases Grand
Rounds, John Radcliffe Infirmary Oxford, United Kingdom, November 28, 2006.
What to do with What’s Lurking Under the Bandage. Continuing Medical Education Day for Family Physicians.
University of Manitoba, March 2, 2007.
What to do with What’s Behind the Door. Northern Infection Prevention and Control Network, Thunder Bay,
Ontario, March 5, 2007.
Antibiotics in Action. Alpha Omega Dental Society, Winnipeg Manitoba. March 6, 2007.
Emergency Medicine Update, Tales from the Trenches: Infectious Diseases in Action. University of Manitoba,
April 20, 2007.
Tales from the Trenches: Infectious Diseases Case History in the Emergency Department. University of Manitoba
Continuing Education Program for Emergency Physicians. University of Manitoba, April 20, 2007.
Drug Resistant Pathogens. Fourth Annual Manitoba Renal Program Conference. Winnipeg, Manitoba, April 23,
2007.
Emerging Antimicrobial Resistant Pathogens. Manitoba Regional Program for Annual General Meeting, Winnipeg,
Manitoba, April 23, 2007.
Helewa RM, Boughen GC, Cheang MS, Embil JM, Goytan M, Zacharias JM. Infectious Spondylodiscitis in Patients
Receiving Hemodialysis. The Canadian Orthopedic Association 62nd Annual Meeting, Halifax, Nova Scotia, June 2,
2007.
Antibiotic Selection for Infection in the Diabetic Foot. International Workshop on Diabetic Foot 2007. Abano,
Italy, June 13, 2007.
Joanne Embree
Dr John Walter’s Memorial Lecture: The Vision for Immunization for Canada. 7th Canadian Immunization
Conference, Winnipeg, Manitoba, December 3-6, 2006.
HPV Vaccine: A New frontier in Immunization. 2nd Trinational Pediatric Meeting of the Mexican Association of
Pediatrics, American Academy of Pediatrics, and the Canadian Paediatric Society, Mexico City, Mexico, Feb 1-2,
2007.
Preventing Neonatal Sepsis. 2nd Trinational Pediatric Meeting of the Mexican Association of Pediatrics, American
Academy of Pediatrics, and the Canadian Paediatric Society, Mexico City, Mexico, Feb 1-2, 2007.
Transmission of STI from Mother to Child. East-West Alliance Meeting, Hong Kong, April 14-15, 2007.
Immunization: Balancing Policy and Good Medicine. 49th Annual Scientific Assembly (College of Family Physicians)
Manitoba. Gimli, Manitoba, May 5-6, 2007.
The Cold Chain Gang: Immunization in the office. 49th Annual Scientific Assembly (College of Family Physicians)
Manitoba. Gimli, Manitoba, May 5-6, 2007.
The University of Manitoba and the University of Nairobi 28 year collaboration. Presentation for the panel
discussion of the Impacts of International Health Research Collaboration at the Meeting of the Health and Public
Policy Association (HPPA), during the 76th Congress of the Humanities and Social Sciences in Saskatoon, May 31,
2007.
Bringing HPV vaccine into your clinical practice. 63rd Annual Clinical Meeting of the Society of Obstetrics and
Gynaecologists of Canada. Ottawa, Ontario, June 21-26, 2007.
Margaret Fast
Canadian Institute of Public Health Inspectors 2007 Branch Conference. April 25-27, 2007. Clarion Hotel.
Winnipeg MB. “The 2006 Winnipeg E. coli Outbreak Re-visited” and “Enteric Investigation Protocols”.
Heinrich Feldmann
Biosynthesis, structure and function of Ebola virus glycoproteins – 90th Canadian Chemistry Conference,
Winnipeg, MB, Canada (2007).
Molecular determinants of Ebola virus virulence – American Society for Microbiology, Toronto, Canada (2007)
Biosafety and Biosecurity in Canada – Euronetp4 Dissemination Meeting, National Institute for Infectious
Diseases, IRCCS Lazzaro Spallanzani, Rome, Italy (2007).
Diagnostic methods for class 4 agents in Canada - Euronetp4 Dissemination Meeting, National Institute for
Infectious Diseases, IRCCS Lazzaro Spallanzani, Rome, Italy (2007).
Emerging zoonotic diseases. Symposium – ‘Animal Disease Control in the 21st Century’, Greifswald/Insel Riems,
Germany (2007).
Pathogenicicty of the 1918 influenza virus. Colloquium – Zentrum für Infektionsbiologie und Immunität, Charite,
Berlin, Germany (2007).
Field laboratory response: Marburg hemorrhagic fever, Rift Valley fever and SARS. Robert-Koch-Institut, Berlin,
Germany (2007).
Biocontainment: necessary component for public health and biodefense. International Symposium on ‘Current
Situation of BSL4 Facilities in the World: Suggestions from the World to Japan. Tokyo, Japan (2007).
The role of filoviruas glycoproteins in pathogenesis and immunity. National Institute for Allergy and Infectious
Diseases, Bethesda, Maryland, USA (2007).
CCHF field laboratory during outbreaks: do we have a test for bedside diagnosis? Joint Intercountry Workshop on
Crimean-Congo Haemorrhagic Fever (CCHF) Prevention and Control, Instanbul, Turkey (2006).
Filoviruses: host adaptation and pathogenesis. Ernst Klenk Symposium, Cologne, Germany (2006).
Filoviruses: recent advances and future challenges. International Centre for Infectious Diseases (ICID) Research
and Innovation Retreat, Winnipeg, Manitoba, Canada (2006).
Vaccines to combat viral hemorrhagic fevers: using a beningn virus to thwart a virlunet one. German Society for
Hygiene and Microbiology, 58th Annual Meeting, Wuerzburg, Germany (2006).
Marburg and Ebola viruses: pathogen versus host defense. American Society for Virology, 25th Annual Meeting.
Madison, Wisconsin, US (2006).
Molecular aspects of viral hemorrhagic fevers. 20th IUBMB International Congress of Biochemistry and Molecular
Biology and 11th FAOBMB Congress, Kyoto, Japan (2006).
Vaccines to combat viral hemorrhagic fevers. University of Tokyo, Tokyo, Japan (2006).
Alan Ferguson
Mapping Transactional Sex on the Trans-Africa Highway:
1) IAS Conference, Toronto, August 2006
2) University of Nairobi Collaborative Meetings Jan 2007
3) Kenya AIDS Prevention Summit, May 2007
Sexual and Reproductive Health Needs of Orphans and Vulnerable Children in Nyanza, Kenya. AED Capable
Partners Forum, May 2007.
Keith Fowke
“Toll-Like Receptors - The New Frontier in Immunization” Plenary Address. 7th Canadian Immunization
Conference. Winnipeg, MB, Dec. 6, 2006.
“Resistance to HIV-1 Infection: A Model of Natural Immunity to HIV Infection” University of Manitoba Faculty of
Pharmacy Research Seminar Series. Dec. 14, 2006.
“Controlling HIV by Studying the Exceptions to the Rule”. University of Manitoba, Department of Chemistry
Seminar Series. April 5, 2007.
“HIV vaccine development: Lessons from nature” Keynote lecture. Summer Institute in Infectious Diseases II:
Issue and Strategies for Intervention on HIV. June 11, 2007.
Lawrence Gelmon
Critical Assumptions and Paradigm Shifts: Lessons in Development from India, Kenya and Elsewhere; presented
at 22nd Highlights in Medicine Conferece, University of Saskatchewan, Saskatoon, Sask, June 20, 2007.
Matthew Gilmour
6th International Symposium on Shiga Toxin (Verocytotoxin)-producing Escherichia coli Infections (VTEC 2006),
October 29th-November 1st, 2006. Melbourne, Australia.
2007 Public Health Agency of Canada Research Forum. Session: ‘Public Health research to improve prevention
and control of foodborne and waterborne zoonoses’. March 12-13th, 2007. Winnipeg, Canada.
Center for Disease Control and Prevention, ‘Salmonella Molecular Serotypingyping Symposium’, (Atlanta, USA):
June, 2006; host: Dr. Patricia Fields.
Gregory Hammond
Making Sense of Clostridium difficile., Presented at Bug Day, October 17, 2006 Theatre A, Basic Medical Sciences
Building, Winnipeg Manitoba.
Introductory remarks at the Partners in Caring (HIV) in Winnipeg, October 18, 2006, Caboto Centre.
How could immunization programs be more useful?? The Provincial / Territorial Perspective or “The Sausage in
the Sandwich”. Presented at the JASP Conference on October 26, 2006 in Montreal, PQ.
Overview of Immunization Committees, Informed Management and Decision-Making. Presented at the JASP
Conference on October 23, in Montreal, PQ.
C. difficile and Associated Diseases. Presented to physicians in Brandon, November 15, 2006.
Vaccines – From Research to Reality. Presented at Eradicating Cervical Cancer Conference, November 17, 2006,
Theatre A, Basic Medical Sciences Building.
The National Immunization Strategy - The View from Here – Provincial / Territorial Perspective, presented at the
7th Canadian Immunization Conference in Winnipeg, December 6 – 10, 2006.
Opening Remarks at the Diabetes and Chronic Disease Prevention Workshop, February 8 – 9, 2007, Canad Inns –
1405 St. Matthews Avenue.
New Vaccine Programs or Not? Lessons for Shaping Public Policy Through Science and Partnership. Presented at
Contemporary Immunology: How the Physical Sciences and Mathematics are Shaping Immunology, Conference
in Vancouver BC, March 12, 2007, Coach House.
C. difficle and Associated Diseases. Presented at St. Boniface General Hospital Internal Medicine Grand Round,
Thursday, May 10, 2007, St. Boniface General Hospital, Winnipeg, Manitoba.
Runtao He
Regulation of NFkB signal transduction pathway by hepatitis B virus X protein. Department of Immunology,
University of Manitoba.
Daryl Hoban
Aug/06 – Invited speaker, Ortho McNeil Pharmaceutical, Dallas
Sept 26/06 – Abbott Ad Board, San Francisco
Oct/06 – Ortho McNeill Pharmaceutical Ad Board, Miami
Oct/06 – Wyeth Centres of Excellence, invited speaker, Toronto
Nov 6/06 – Invited speaker, Bayer, Winnipeg
Nov 7-9/06 – Invited speaking tour, Abbott, Vancouver
Nov 16/06 – Invited speaker, Ortho McNeil Pharmaceutical, Chicago
Nov 17/06 – Invited speaker, Abbott Ad Board, Calgary
Nov 30/06 – Invited speaker, INIS Symposium, Winnipeg
Jan 24-26/07 – Invited speaker, Abbott Symposiums, Calgary & Edmonton
Mar 6-9/07 – Invited speaking tour, Ortho McNeil Pharmaceutical, Fresno, CA
May 12-17/07 – Invited speaking tour in Iran, Abbott
June 2/07 – Wyeth Ad Board, Victoria
June 4/07 – Abbott Symposium, Victoria
Steven J.M. Jones
Tsinghua University, Beijing, China. May 2007. Invited Speaker. Title: Massively parallel sequencing approaches
for the determination of histone modifications and transcription factor binding sites.
16th International Congress of Cytology. Vancouver, BC. May 2007. Invited Speaker. Title: Determining genomic
changes through Bioinformatics.
AGBT Conference, Marco Island, Florida. Feb. 2007. Invited Speaker. Title: Massively Parallel Sequencing-BySynthesis for Detection of Genetic Aberrations in Human Cancer.
Monsanto, St. Louis, Missouri. Dec. 2006. Invited Speaker. Title: High-throughput computational identification of
gene regulatory elements.
Genomics Mini Symposium, Simon Fraser University, Vancouver, BC. Dec. 2006. Invited Speaker.
Steven M. Jones
2006 - Mobile Laboratories: Crime Scene Management and Chain of Custody. Interpol Regional Bioterrorism
Training. Santiago de Chile.
2006 - Mobile Laboratories: Crime Scene Agent Identification and Chain of Custody CIS/CSFS Workshop Windsor,
ON.
2006 - Technical Response Group Meeting: Canadian Update, , AUSCANUKUS Quadralateral Meeting Porton Down
UK.
2006 - The Characterization of anti-Ebola Monoclonal Antibodies. CRTI Annual Research Forum Gatineaux, QC
Canada.
2006 - The Magic Bullet: VSV Vaccines and Therapy ICID International Filovirus Winnipeg Mb Canada.
2006 - Pre and Post-Exposure Prophylaxis for Marburg and Ebola Viruses: Use of Benign Recombinant Viruses to
Combat Highly Lethal Pathogens. Seventh Canadian Immunization Conference, Winnipeg MB.
2006 - Marburg Outbreak in Uige, Angola: Diagnostic Field Response Public Health Agency of Canada National
Science Week Ottawa.
2006 - Science goes to the movies Outbreak Fact or Fiction (2006) National Science Museum Ottawa.
Joshua Kimani
VCT Programs – Are we making progress! Lessons Learnt from Kenya- Ministry of Health – Lesotho - Sept 2006.
PMTCT Best Practices in Kenya – PMTCT Stakeholders forum in Nairobi, Kenya- August 2007.
Thomas Klonisch
Pathology Seminar, Nov. 2006
CancerCare Manitoba Seminar Series, Jan. 2007
Pharmacology Seminar, March 2007
Denis Krause
Microbial etiologies in inflammatory bowel disease. Gut Forum, University of Manitoba, 5 June 2007.
Invited scientific talk (2006) Serine protease autotransporters (SPATE) and autoaggregative adhesins from
Escherichia coli are potential virulence factors in inflammatory bowel disease. Gut Microbiology 2006: 5th Biennial
Meeting. Aberdeen, UK.
Impact of Ruminant Feeding Programs on the Development of SARA (Sub-Acute Ruminal Acidosis). 27th Western
Nutrition Conference, Fort Garry Hotel, Winnipeg, Manitoba, Canada.
Microbial ecology of inflammatory bowel disease. Department of Entomology. 16 th September, 2006.
Subacute ruminal acidosis, the physiological causes consequences and incidence. “Production Diseases of the
Transition Cow” University College Dublin, Dublin Ireland, September 28-29, 2006: 19-20.
Is inflammatory bowel disease a polymicrobial disease? University of Alberta, Canada, April 11, 2007.
Serine protease autotransporters produced by Escherichia coli may be a virulence factor in IBD. June 29, 2007,
Lille, France. (Eventually did not give the talk)
Carbohydrate fermentation in the rumen. 7th International Symposium on the Nutrition of Herbivores (ISNH-7),
17th to 22nd September 2007, Beijing, China.
Sustainable feed management strategies to reduce ruminant pathogen shedding in the environment. Abstract
CNC_W-3-01. Canadian Nutrition Congress, June 18 – 21, Winnipeg, Canada.
Is inflammatory bowel disease a polymicrobial disorder. Richardson Centre for Functional Foods and
Neutraceuticals. 30th October, 2007.
Is there an IBD bug out there? 1st November, 2007. Saskatoon Chapter of Crohn’s and Colitis Foundation of
Canada.
Is there an IBD bug out there? 2nd November, 2007. Regina Chapter of the Crohn’s and Colitis Foundation of
Canada.
Anand Kumar
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Wyeth
Advisory Board Meeting (Toronto, ON) October 15, 2006.
Septic Shock: Optimizing outcome by optimizing antimicrobial therapy. University of California, Bakersfield Grand
Rounds, Kern Medical Centre (Bakersfield, CA). October 19, 2006.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Toronto
Critical Critical Care Medicine Symposium (Toronto, ON) October 27, 2006.
Antimicrobial therapy of sepsis and septic shock. International Nosocomial Infection Symposium (Winnipeg, MB)
Nov 30, 2006.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. St. Agnes
Hospital Critical Care Grand Rounds (Baltimore, Maryland) December 13, 2006.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Cooper
University Hospital Critical Care Grand Rounds (Camden, NJ) December 14, 2006.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Association of Medical Microbiology and Infectious Diseases Canada and Canadian Association for Clinical
Microbiology and Infectious Diseases Annual Conference (Halifax, NS) March 15, 2007.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Critical
Care Grand Rounds, Queen Elizabeth Medical Center, Dalhousie Medical School (Halifax, NX) March 16, 2007.
Antimicrobial and supportive therapy of sepsis and septic shock. Winnipeg Regional Health Authority ER Triage
Nurse Educational Meetings (Winnipeg, MB) April 4, 2007.
Antimicrobial and supportive therapy of sepsis and septic shock. Winnipeg Regional Health Authority ER Triage
Nurse Educational Meetings (Winnipeg, MB) April 5, 2007.
Antimicrobial and supportive therapy of sepsis and septic shock. Winnipeg Regional Health Authority ER Triage
Nurse Educational Meetings (Winnipeg, MB) April 11, 2007.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Infectious
Diseases Grand Rounds, Victoria Hospital, University of London, Faculty of Medicine (London, ON) April 25, 2007.
Optimizing Outcomes: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
University Health Network CME Rounds, University of Toronto (Toronto, ON) April 25, 2007.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Medical/Surgical Grand Rounds, Grand River/Kitchener-Waterloo Hospital (London, ON) April 26, 2007.
Septic Shock: Optimizing Outcomes. Critical Care Medicine City-wide Grand Rounds, Victoria Hospital, University
of London, Faculty of Medicine (London, ON) April 27, 2007.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Medical/Surgical Grand Rounds, Nanaimo Regional General Hospital (Nanaimo, BC) May 1, 2007.
Septic Shock: Optimizing Outcomes. Royal Jubilee/Victoria General Hospitals Combined CME Rounds, University
of Victoria, Faculty of Medicine (Victoria, BC) May 1, 2007.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Royal
Columbian Hospital CME Lecture (New Westminster, BC) May 2, 2007.
Optimizing Outcomes: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Respiratory/Critical Care Medicine Rounds, Surrey Memorial Hospital (Surrey, BC) May 3, 2007.
Optimizing Outcomes: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Vancouver General Hospital/St. Paul’s Hospital CME Lecture (Vancouver, BC) May 3, 2007.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Regina
Regional Health Authority CME lecture (Regina, SK) June 4, 2007.
Optimizing Outcomes: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Critical Care Medicine Rounds, University Hospital (Edmonton, AB) June 5, 2007.
Optimizing Outcomes: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Critical Care Medicine Rounds, Foothills Hospital, University of Calgary (Calgary, AB) June 6, 2007.
Sepsis and Septic Shock. Optimizing Outcomes. Grand Rounds, Southlake Hospital (Newmarket, ON) June 25,
2007.
Septic Shock: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database. Grand
Rounds, Humber River Regional Hospital (Weston, ON) June 25, 2007.
Optimizing Outcomes: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Critical Care Medicine Rounds, Hamilton General Hospital, McMaster University (Hamilton, ON) June 25, 2007.
Optimizing Outcomes: Lessons from the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database.
Infectious Diseases Rounds, Sunnybrook Hospital, University of Toronto (Toronto, ON) June 26, 2007.
Sepsis and Septic Shock. Optimizing Outcomes. Tri-hospital Critical Care CME lecture, Sunnybrook, North York
General, Scarborough General Hospitals (Toronto, ON) June 26, 2007.
Sepsis and Septic Shock. Optimizing Outcomes. Critical Care Medicine Rounds, Windsor Regional Hospital and
Hotel Dieu Grace Hospital (Windsor, ON) June 27, 2007.
Yan Li
Invited as a keynote speaker by the Life Science Department of Natural Science Foundation of China (NSFC) and
the Academy of Military Medical Science (AMMS) to give a plenary lecture on new emerging human respiratory
virus, human metapneumovirus at the Ninth International Life Scientific Forum and chaired a session on viral
infection and transmission mechanism (September 25-28, 2006).
Invited a speaker to give a talk “Emerging Respiratory Virus Threat: Avian Influenza” and chaired the breakout
session “Pandemic Influenza: From surveillance to Vaccines” at the 2 nd Annual Public Health Agency of Canada
(PHAC) Research Forum, Winnipeg, MB, Canada (March 12-13, 2007).
Stephen Moses
Invited speaker, International Conference on Actions to Strengthen Linkages between Sexual and Reproductive
Health and HIV/AIDS, Mumbai, India, February 4-8, 2007: “Male circumcision for the prevention of HIV
transmission”.
Michael Mulvey
Invited Speaker. Pseudomembranous Colitis: The New Epidemic. International Nosocomial Infection Surveillance
Program, University of Manitoba, Winnipeg, Canada, November 30, 2006.
Invited Speaker. Controlling Antimicrobial Resistance in Canada: A Complex Problem in Both Human and
Animals. Professional Development Week, National Pharmacy Student Conference, Winnipeg, Canada, January
18, 2007.
Invited Speaker and Meeting Organizer. Clostridium difficile in Animals, Food, and the Environment Strategic
Planning, Guelph, Canada February 28-29, 2007.
Invited Speaker. Clostridium difficile Surveillance in Canada. Alberta Micronet. Calgary, Alberta. March 8, 2007.
Session Organizer/Speaker. Superbug surveillance in our hospitals. Public Health Research Forum. Winnipeg,
May, 2007.
Invited Speaker. The Emergence of Antimicrobial Resistant Superbugs: Are We Winning the Battle? Canadian
Institute of Public Health Inspectors. Winnipeg, Canada. April 26, 2007.
Celine Nadon
April 16, 2007. “PulseNet Canada 2006: Achievements and New Challenges”.
PulseNet International /Association of Public Health Laboratories Annual Meeting, Providence, Rhode Island.
October 20, 2006. “PulseNet Canada Update and the Global Salmonella Typhi Database Project”. Canadian
Public Health Laboratory Network Semi-Annual Meeting, Winnipeg, Canada.
Lai-King Ng
Water and Food Safety Subcommittee Update. CPHLN Semi-Annual Meeting, Montreal, Quebec, Apr 12-13, 2007.
An Overview of Bacteriology and Enteric Diseases Program Activities. Hong Kong, December 22, 2006.
What is PulseNet? WHO GSS Workshop PulseNet Asia Pacific, Beijing, China, December 7-8, 2006.
Science Network. WHO GSS Workshop PulseNet Asia Pacific, Beijing, China, December 7-8, 2006.
Wassay Niazi
Skylark Medical Clinic, Winnipeg, July 27thMeeting -Afghanistan- what can Canadians do. Read About the Stop
Afghan AIDS program to Help By Dr Niazi Wassay of Afghanistan, www.skylarkmedicalclinic.com/2006links.htm.
CBC Radio 1 panel on Canadian Forces in Afghanistan, September 7, 2006.
Lindsay Nicolle
Invited Speaker. “Shining the Light of Reason on Asymptomatic Bacteriuria” Medical Grand Rounds, University of
North Dakota, Grand Forks, September 13, 2006.
Invited speaker. “Blowing in the wind: Protecting ourselves from aerosol and droplet spread micro-organisms”.
Bug Day, Health Sciences Centre, Winnipeg, MB. October 17, 2006.
Invited faculty. “Emerging Infectious Disease Issues in Long Term Care”, “Infection Control in Long Term Care
Settings”, “Approach to Bacteriuria in Long Term Care Settings”. University of Wisconsin, Madison, Wisconsin,
October 23, 2006.
Workshop Presenter and Facilitator. Infectious Disease Control Training Centre Hospital Authority/Infection
Control Branch, Centre for Health Protection. Infection Control Training in Long Term Care Facilities – Hong Kong
Level I – 22-24 Nov. 2006, Level II – 27-28 Nov. 2006
Keynote Speaker “Nosocomial Urinary Tract Infection” International Nosocomial Infection, University of
Manitoba, Winnipeg, Nov. 30, 2006.
Speaker “Problem UTI’s” Friday at Noon CME, University of Manitoba, January 19, 2007.
Invited Speaker “Success and failure with short-term therapy” in symposium: Updates on Pathogenesis and
Epidemiology of Community Acquired UTI. 17th ECCMIP and 25th ICC Munich, Mar 31, 2007.
Deborah Nowicki
VTEC Outbreak, Winnipeg Health Region, August 2006. Canadian Institute of Public Health Inspectors, Manitoba
Branch, 20th Annual Educational Conference, Winnipeg, Manitoba, April 26, 2007.
The Epidemiology of Sexually Transmitted Infections in the Winnipeg Health Region. Winnipeg Regional Health
Authority Population and Public Health Staff Development Sessions, June 12, 14, 2007.
Pamela Orr
Invited Speaker, Partners in Caring Conference (PHAC sponsored), Winnipeg, October 20, 2006: “Tuberculosis
and its Fellow Travelers: HIV and other STIs”.
Invited Speaker, Canadian Immunization Conference, Winnipeg, December 5, 2006: “Does Life Begin After 50?
Influenza Vaccination for Those Age 50-64 Years”.
Update on CTC TB Guidelines. First Nations and Inuit Health Branch, Manitoba Region, February 13, 2007.
History of Tuberculosis, MKO TB Conference, Thompson, Manitoba, March 2007.
Why are TB rates still high in Manitoba and what can be done about it? Department of Pharmacology and
Therapeutics, University of Manitoba, April 2007.
Rosanna Peeling
July 26-30, 2006. Kuala Lumpur, Malaysia, International Union against STI Asia Pacific Meeting , Rapid Tests for
STIs: A Brave New World for STI Control.
Sept 3-7, 2006. Port au Prince, Haiti National Consultation on Syphilis Screening Update on Rapid Syphilis Tests.
Sept 27-30, 2006. San Francisco, USA. ICAAC. The Epidemiology of STIs in Sexual Abuse.
Oct 14-18, 2006. Bangkok, Thailand. WHO GCLP/biobanking workshop. Quality Standards for BioBanks and
Laboratories in Clinical Trials.
Oct 19-21, 2006. Versailles France. IUSTI Europe. The Use of Rapid Syphilis Tests.
Oct 26-30, 2006. Nanjing, China. China Syphilis Meeting. Control of STIs: Will Rapid Tests Make a Difference?
Dec 1, 2006. Seattle, USA. Diagnostic Target Discovery Meeting. Diagnostics Research and Development for
Infectious Diseases in the Developing World.
Dec 4-8, 2006. Panama City. GCLP/biobanking workshop.
Jan 23, 2007. Geneva, Switzerland. WHO/TDR Seminar Series. Avoiding HIV and Dying of Syphilis:The Tragedy of
Babies in the Developing World.
March 5-7, 2007. Rabat, Morocco. National Institute for Hygiene. Rapid Syphilis Tests.
March 12-23, 2007. China. Schisto and STI Meeting.
April 4, 2007. Varanasi, India. VL Meeting.
April 15-18, 2007. Hawaii, USA. Pediatric Dengue Vaccine Initiative Meeting. The WHO/TDR- PDVI Collaboration
on Evaluation of Dengue Diagnostics.
May 1-4, 2007. Blackpool, England. British Association for Sexual Health and HIV How Close Are We to Reliable
Near-Patient Tests for STIs?
Pierre Plourde
Post-travel clinical case studies (CME presented in Boundary Trails Hospital, Manitoba) – October 5, 2006.
Tropical Medicine Interactive Symposium (Infectious Diseases Society of America 44 th Annual Meeting, Toronto) –
October 15, 2006.
Bringing Home Unwelcome Guests: Infections Acquired While Travelling (Bug Day, University of Manitoba) –
October 17, 2006.
Reducing Adverse Events Through Infection Control Across the Continuum (Provincial Safety Conference: Leading
us to Excellence, Winnipeg) – October 25, 2006.
What’s New in Travel Vaccines (Infectious Diseases Update: International and Travel Medicine Conference,
Victoria BC) – November 4, 2006.
Preparing Health Care Workers for International Travel (Infectious Diseases Update: International and Travel
Medicine Conference, Victoria BC) – November 4, 2006.
Travel Vaccines (7th Canadian Immunization Conference, Winnipeg) – December 3, 2006.
Post-travel Management Case Studies (Preventive Occupational and Environmental Medicine Group, Manitoba
Medical Association, Winnipeg) – January 11, 2007.
Travel Vaccines Update (CME presented to family physicians in Winnipeg) – January 24, 2007.
Can anything good come out of an Influenza Pandemic? 1918-19 “Spanish” Flu Lessons Learned (Ethics Forum
on Pandemic Preparedness, St. Boniface General Hospital, Winnipeg) – January 30, 2007.
In the Eye of the Storm: Working in “Difficult Partnership” Countries (Canadian Institute of Public Health
Inspectors 2007 Manitoba Branch Conference: Planning in the Calm Before the Storm, Winnipeg) – April 26,
2007.
The 2006 Winnipeg E. coli Outbreak: Re-Visited (Canadian Institute of Public Health Inspectors 2007 Manitoba
Branch Conference: Planning in the Calm Before the Storm, Winnipeg) – April 26, 2007.
A Gut Feeling: Small Round Enteric Virus (Annual CHICA Manitoba Infection Prevention and Control Conference:
The Bug Stops Here! Your Role in Infection Control! – Winnipeg) – June 1, 2007.
Travel Immunizations and Malaria Prevention (CME presented to family physicians in Saskatoon) – June 5, 2007.
Eosinophilia in Refugees (CME presented to family physicians in Winnipeg) – June 21, 2007.
Frank Plummer
August 2006. International AIDS Conference 2006, Toronto, Basic Science Track Conference Co-Chair.
September 2006. Third International Conference on Filoviruses, Winnipeg, Natural Resistance to HIV Infection.
Frank Schweizer
Effects of glycosylation of (2S,4R)-4-hydroxyproline on the conformation, kinetics and thermodynamics of prolyl
amide isomerization. Gordon Research Conference, Tilton New Hampshire, May, 18, 2007 ( invited oral poster
highlight presentation).
Synthesis and properties of conformationally-constrained glycopeptides (invited). Canadian Chemistry Conference,
Halifax, NS, May 28, 2006.
Synthesis and properties of glycosylated hydroxyproline containing model peptides. Canadian Chemistry
Conference, Halifax, NS, May 30, 2006.
Alberto Severini
“HPV surveillance in the era of HPV vaccination” Invited speaker, Roche Minisymposium at the AMMI/CACMID
Annual Conference, Halifax, Canada, March 14-8, 2007.
Meenu Sharma
May 2007. 107th American Society of Microbiology General Meeting, Toronto.
March 2007. 2nd Public Health Agency of Canada Research Forum, Winnipeg.
James Strong
“The Ras/MAPK Pathway Enhances Ebola Virus Infectivity: A Potential Mechanism to Break Virus Dormancy in the
Natural Reservoir. Presented to Filoviruses: Recent advances and future challenges, An ICID Global Symposium,
Winnipeg, Manitoba, September 17-19, 2006.
Graham Tipples
Presentation: Measles and rubella laboratory diagnosis: challenges in the elimination phase
Canadian Measles Reference Laboratory Representative for the Pan-American Health Organization Technical
Advisory Group on Vaccine Preventable Diseases Meeting. Guatemala City, Guatemala, July 24-27, 2006.
Stefan Wagener
2006 Beijing, Singapore, Brussels
2007 Bangkok, Boston, Nairobi
Hana Weingartl
Nipah, Hendra and Crimean-Congo-Hemorrhagic-fever viruses: re-emerging, virulent and zoonotic pathogens,
Abstract/Oral presentation; June 25 – 29, 2006. International veterinary Vaccines and Diagnostics Conference,
Oslo, Norway.
John Wylie
Review of recent STI and BBP research in Manitoba. 2007. Presented to Public Health Nurses and Program
Managers staff of the Winnipeg Regional Health Authority.
Review of STI research in Manitoba, 1996-2007. 2007. Presented to staff of the Public Health Branch, Manitoba
Health.
Bloodborne pathogens and risk behaviours: the influence of social networks. The University of Winnipeg Global
College Summer Institute in Infectious Disease 2007.
Verotoxin-producing E. coli outbreak in Winnipeg, Manitoba. 2007. Canadian Institute of Public Health
Inspectors, Winnipeg, Manitoba.
Combining social network, geographic, and molecular data to identify pathogen transmission patterns. 2007. IV
Biennial Netropica conference, La Ceiba, Honduras.
Manitoba Pulsenet. Presentation requested for National Meeting on Pulsenet Canada. Winnipeg, Manitoba, 2007.
CA-MRSA in Manitoba. Presentation requested for National meeting on community-associated MRSA in Canada.
Winnipeg, Manitoba, October, 2006.
MRSA and VRE investigation at Cadham Provincial Laboratory. Presentation requested by the Manitoba chapter
of CHICA, September, 2006.
Update on I-track. Presentation requested by the Prairie Region HIV/AIDS Community Based Research Network.
2006.
Xi Yang
Invited Speaker, Role of NKT cell in chlamydial infection, Section of Cellular and Molecular Biology, Sunnybrook
Hospital, University of Toronto, Toronto, Aug. 2006.
Invited Speaker, NKT and chlamydial infection, The University of Texas Health Science Center at San Antonio,
Nov 2006.
Xiao-Jian Yao
Functional roles of HIV-1 integrase in early stage of viral replication. International Centre for Infectious Diseases
Research and Innovation Retreat. Winnipeg, MB Canada, Oct 23-25, 2006.
Interaction of HIV-1 integrase and cellular factor and their functional roles during viral replication. WORLD AIDS
DAY-CHINA. Tianjin China Dec 1 to 3, 2006.
A Hard Way to Host Nucleus: The Essential Step for HIV-1 Replication. Second Peguis First Nation Science
Engineering and Technology Symposium, U. Manitoba, Winnipeg. Feb 16, 2007.
George Zhanel
“The use of pharmacokinetics and pharmacodynamics in the treatment of infections in patients with cystic
fibrosis” Presented to the Pediatric and Adult Cystic Fibrosis team, Health Sciences center, Winnipeg, Manitoba,
October 13, 2006.
“Infections caused by resistant superbugs: From DNA to the bedside ” Presented at the 2006 International Center
for Infectious Diseases Research and Innovation Retreat, Winnipeg, Manitoba, October 24, 2006.
“Treatment of community-associated MRSA infections in the community and hospital ” Presented at infectious
diseases, respiratory and critical care rounds, San Diego, California, November 13, 2006.
“Multidrug resistant infections infections in the hospital setting ” Presented at infectious diseases/medical
microbiology rounds, San Diego, California, November 14, 2006.
“Infections in the intensive care unit: Treat early and aggressively by optimizing antimicrobial pharmacodynamics”
Presented at infectious diseases, respiratory and critical care rounds, Los Angeles, California, November 15, 2006.
“Treat early, aggressively, using combinations and then de-escalate when treating intensive care unit infections ”
Presented at infectious diseases/medical microbiology rounds, Los Angeles, California, November 16, 2006.
“Final results of the Canadian Intensive Care Unit Study (CAN-ICU): Focus on Ontario data ” Presented at critical
care rounds, Hamilton Health Sciences Center, Hamilton, Ontario, November 27, 2006.
“The worldwide spread of antibiotic resistant superbugs: Are we doomed ? ” Presented at research day hosted by
medical affairs, Wyeth Pharmaceuticals, Toronto, Ontario, November 28, 2006.
“Antibiotic resistant infections in Canadian hospitals: Focus of extended spectrum B-lactamase producing
organisms ? ” Presented at city wide infectious diseases rounds, Sunnybrook Health Sciences Center, Toronto,
Ontario, November 28, 2006.
“How best to manage infections in the ICU: Focus on Canadian data ? ” Presented at city wide critical care
rounds, St. Michaels hospital, Toronto, Ontario, November 28, 2006.
“MRSA infections: Whats the data and how to manage these patients ? ” Presented at infectious diseases/medical
microbiology postdoctoral fellows academic day, Winnipeg, Manitoba, December 6, 2006.
“Antibiotic resistance in British Columbia/Alberta: Comparison with Canada ? ” Presented at infectious diseases
rounds, Vancouver General and Health Sciences Center, Vancouver, British Columbia, December 7, 2006.
“Treatment of antibiotic resistant infections: Focus on new antimicrobials ? ” Presented at medical microbiology
rounds, Vancouver General and Health Sciences Center, Vancouver, British Columbia, December 7, 2006.
“Solutions to antimicrobial resistant infections: Infection control, vaccination, optimizing pharmacodynamics and
new antibiotics ” Presented at a specialist update, Vancouver, British Columbia, December 7, 2006.
“Microbiology and resistance issues in intraabdominal infections ” Presented at the Canadian intraabdominal
infectious guidelines group, Toronto, Ontario, December 8, 2006.
“Infections caused by antibiotic resistant superbugs: Are we doomed ?” Presented at the Annual Conference of
Professional Development Week (PDW), Winnipeg, Manitoba, January 18, 2007.
“The global spread of multi-drug resistant pathogens: The critical need for new antimicrobials ” Presented at
Chemistry Rounds, Department of Chemistry/Biochemistry, University of Manitoba, Winnipeg, Manitoba, January
19, 2007.
“What can we do about the worldwide spread of infections caused by antimicrobial resistant organisms”
Presented at Presented at infectious diseases, respiratory and critical care rounds, Reno, Nevada, January 22,
2007.
“Infection control, vaccination, appropriate antimicrobial use and development of new antimicrobials are the key
to slow the progression of resistant pathogens” Presented microbiology/infectious diseases, respiratory and
emergency rounds, Portland, Oregon, January 23, 2007.
“Optimizing pharmacodynamics is the key to treating critically ill patients with antimicrobial resistant infections”
Presented at respiratory, critical care, microbiology/infectious diseases and emergency rounds, Seattle,
Washington, January 24, 2007.
“Past, present and future of the Canadian Antimicrobial Resistance Alliance (CARA) and the can-r website”
Presented at the annual ca-r editorial meeting, Toronto, Ontario, January 30, 2007.
“Infections caused by antibiotic resistant superbugs: Are we doomed ? ” Presented at the Get to know your
research at your University series, University of Manitoba, Winnipeg, Manitoba, February 20, 2007.
“Management of infections caused by resistant organisms: New antibiotics on the horizon ? ” Presented at a
specialist update, Phoenix, Arizona, Feb 28, 2007.
“Antimicrobial resistance in intensive care units in Canada ” Presented at New Insights into Infections in the
Canadian ICU setting, Symposia of the Association of Medical Microbiology and Infectious Diseases in Canada
(AMMI), Halifax, Nova Scotia, March 15, 2007.
“Microbiological, pharmacokinetic and pharmacodynamic properties of ceftobiprole: Comparison to ceftriaxone,
cefotaxime, ceftazidime and cefepime ” Presented at an infectious diseases/medical microbiology ceftobiprole
meeting, Toronto, Ontario, April 12, 2007.
“What can surgeons do about antibiotic resistant pathogens/infections: Infection control and antibiotic
stewardship ” Presented at Surgery Grand Rounds, Health Sciences Center, Winnipeg, Manitoba, April 25, 2007.
“What’s in the future for science students graduates from the University of Manitoba ? ” Presented at the
University of Manitoba Science Students Association (SSA) graduation, Winnipeg, Manitoba, April 28, 2007.
“Research progress from the Canadian Antimicrobial Resistance Alliance (CARA)”, Presented to the department of
Medical Microbiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, May 7, 2007.
“What is the benefit to Manitobans from research conducted by the Canadian Antimicrobial Resistance Alliance
(CARA)”, Presented to a business group of Winnipeg, Winnipeg, Manitoba, May 25, 2007.
“Antibiotic resistance issues in cystic fibrosis: Microbiological and pharmacological issues ” Presented at a cystic
fibrosis meeting, Toronto, Ontario, June 1, 2007.